ICD-10-CM Diagnosis Code T51.3X3D - Toxic effect of fusel oil, assault, subsequent encounter (original) (raw)
ICD List 2025-2026 Edition
- Home
- ICD-10-CM Codes
- S00–T88
- T51-T65
- T51
- 2026 ICD-10-CM Code T51.3X3D
Toxic effect of fusel oil, assault, subsequent encounter
ICD-10-CM Code:
T51.3X3D
ICD-10 Code for:
Toxic effect of fusel oil, assault, subsequent encounter
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Not chronic
Code Navigator:
T51.3X3D is a billable diagnosis code used to specify a medical diagnosis of toxic effect of fusel oil, assault, subsequent encounter. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2025 through September 30, 2026. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.
T51.3X3D is a subsequent encounter code, includes a 7th character and should be used after the patient has completed active treatment for a condition like toxic effect of fusel oil assault. According to ICD-10-CM Guidelines a "subsequent encounter" occurs when the patient is receiving routine care for the condition during the healing or recovery phase of treatment. Subsequent diagnosis codes are appropriate during the recovery phase, no matter how many times the patient has seen the provider for this condition. If the provider needs to adjust the patient's care plan due to a setback or other complication, the encounter becomes active again.
- Code Information
- Clinical Classification
- Coding Guidelines
- Tabular List of Diseases and Injuries
- Diagnostic Related Groups Mapping
- Present on Admission (POA)
- Convert to ICD-9 Code
- Table of Drugs and Chemicals
- Patient Education
- Other Codes Used Similar Conditions
- Code History
- Injury, poisoning and certain other consequences of external causes
S00–T88
Clinical Classifications group individual ICD-10-CM diagnosis codes into broader, clinically meaningful categories. These categories help simplify complex data by organizing related conditions under common clinical themes.
They are especially useful for data analysis, reporting, and clinical decision-making. Even when diagnosis codes differ, similar conditions can be grouped together based on their clinical relevance. Each category is assigned a unique CCSR code that represents a specific clinical concept, often tied to a body system or medical specialty.
CCSR Code: INJ060
Inpatient Default: Y - Yes, default inpatient assignment for principal diagnosis or first-listed diagnosis.
Outpatient Default: Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.
The appropriate 7th character is to be added to each code from block Toxic effect of alcohol (T51). Use the following options for the aplicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
T51.3X3D is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.
CMS POA Indicator Options and Definitions
POA Indicator: Y
Reason: Diagnosis was present at time of inpatient admission.
CMS Pays CC/MCC DRG? YES
POA Indicator: N
Reason: Diagnosis was not present at time of inpatient admission.
CMS Pays CC/MCC DRG? NO
POA Indicator: U
Reason: Documentation insufficient to determine if the condition was present at the time of inpatient admission.
CMS Pays CC/MCC DRG? NO
POA Indicator: W
Reason: Clinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.
CMS Pays CC/MCC DRG? YES
POA Indicator: 1
Reason: Unreported/Not used - Exempt from POA reporting.
CMS Pays CC/MCC DRG? NO
Below are the ICD-9 codes that most closely match this ICD-10 code, based on the General Equivalence Mappings (GEMs). This ICD-10 to ICD-9 crosswalk tool is helpful for coders who need to reference legacy diagnosis codes for audits, historical claims, or approximate code comparisons.
ICD-9-CM: V58.89
Approximate Flag - The approximate mapping means this ICD-10 code does not have an exact ICD-9 equivalent. The matched code is the closest available option, but it may not fully capture the original diagnosis or clinical intent.
The parent code T51.3X3 of the current diagnosis code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.
According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.
Filter table of drugs and chemicals:
| Substance | Poisoning Accidental (unintentional) | Poisoning Accidental (self-harm) | Poisoning Assault | Poisoning Undetermined | Adverse effect | Underdosing |
|---|---|---|---|---|---|---|
| 1-propanol | T51.3X1 | T51.3X2 | T51.3X3 | T51.3X4 | ||
| Butanol | T51.3X1 | T51.3X2 | T51.3X3 | T51.3X4 | ||
| Fusel oil (any) (amyl) (butyl) (propyl), vapor | T51.3X1 | T51.3X2 | T51.3X3 | T51.3X4 | ||
| Pentanol | T51.3X1 | T51.3X2 | T51.3X3 | T51.3X4 | ||
| 1-Propanol | T51.3X1 | T51.3X2 | T51.3X3 | T51.3X4 | ||
| Propyl | T51.3X1 | T51.3X2 | T51.3X3 | T51.3X4 | ||
| Propyl »alcohol | T51.3X1 | T51.3X2 | T51.3X3 | T51.3X4 | ||
| Propyl »carbinol | T51.3X1 | T51.3X2 | T51.3X3 | T51.3X4 | ||
| Propyl »hexadrine | T51.3X1 | T51.3X2 | T51.3X3 | T51.3X4 | ||
| Propyl »iodone | T51.3X1 | T51.3X2 | T51.3X3 | T51.3X4 | ||
| Propyl »thiouracil | T51.3X1 | T51.3X2 | T51.3X3 | T51.3X4 | ||
| Trimethylcarbinol | T51.3X1 | T51.3X2 | T51.3X3 | T51.3X4 |
FY 2026 - No Change, effective from 10/1/2025 through 9/30/2026
FY 2025 - No Change, effective from 10/1/2024 through 9/30/2025
FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.
